{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:30:03Z","timestamp":1789266603425,"version":"build-2803163510"},"reference-count":135,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,3,12]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Pyridazinone analogs possess diverse types of pharmacological activities, such as anticancer, antimicrobial, anticonvulsant, analgesic, anti-inflammatory, antioxidant, antihypertensive, antisecretory, antiulcer, and other useful pharmacological activities. They also possess cyclooxygenase (COX) inhibitors, dipeptidyl peptidase inhibitors, phosphodiesterase inhibitors, glutamate transporter activators, adenosine receptor antagonists, serotonin receptors antagonists, lipooxygenase, cholinesterase, vasodilator, and anesthetics. Pyridazine rings are the essential structure for some marketed drugs, such as pimobendan, levosimendan as a cardiotonic drug, and emorfozan as an analgesic and anti-inflammatory (Non-steroidal anti-inflammatory drug) agent. So, researchers all over the world have paid attention to synthesizing various pyridazinone compounds mainly due to the ease of design and synthesis of different analogs and variables in the pharmacological responses. This review article focuses on the pharmacological activities of different pyridazine analogs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406419666230913102835","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:17:13Z","timestamp":1694701033000},"page":"245-267","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Diverse Pharmacological Potential of Pyridazine Analogs against Various Diseases"],"prefix":"10.2174","volume":"20","author":[{"given":"Ahad Amer","family":"Alsaiari","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-8667","authenticated-orcid":true,"given":"Mazen M.","family":"Almehmadi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-3462","authenticated-orcid":true,"given":"Mohammad","family":"Asif","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Era College of Pharmacy, Era University, Lucknow, 226003, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1","volume":"35","author":"G\u00f6k\u00e7e M.","year":"2010","unstructured":"G\u00f6k\u00e7e M.; D\u00fcndar Y.; K\u00fcpelg E.; Synthesis of (6-substituted-3 (2H)-pyridazinon-2-yl) acetic acid and (6-substituted-3 (2H)-pyridazinon-2-yl) acetamide derivatives and investigation of their analgesic and anti-inflammatory activities. FABAD J Pharm Sci 2010,35,1-11","journal-title":"FABAD J Pharm Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1570193X19666220329155551","volume":"20","author":"Asif M.","year":"2023","unstructured":"Asif M.; Alghamdi S.; A mini-review on pyridazine analogs: Chemical and pharmacological potentials. Mini Rev Org Chem 2023,20(2),100-123","journal-title":"Mini Rev Org Chem"},{"key":"ref=3","first-page":"71","volume":"8","author":"Alang G.","year":"2011","unstructured":"Alang G.; Kaur R.; Singh A.; Budhlakoti P.; Singh A.; Synthesis, characterization and anti-bacterial activity of certain 2,3,4,5-tetrahydropyridazinone analogues. Turk J Pharm Sci 2011,8,71-80","journal-title":"Turk J Pharm Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acs.jmedchem.2c01668","volume":"66","author":"Al-Karmalawy A.A.","year":"2023","unstructured":"Al-Karmalawy A.A.; Nafie M.S.; Shaldam M.A.; Elmaaty A.A.; Antar S.A.; El-Hamaky A.A.; Saleh M.A.; Elkamhawy A.; Tawfik HO.; Ligand-based design on the dog-bone-shaped BIBR1532 pharmacophoric features and synthesis of novel analogues as promising telomerase inhibitors with in vitro and in vivo evaluations. J Med Chem 2023,66,777-792","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2011\/873470","volume":"8","author":"Samanta K.C.","year":"2011","unstructured":"Samanta K.C.; Asif M.; Garg V.; Sharma P.; Singh R.; Synthesis of different substituted pyridazinone derivatives and their anticonvulsant activity. J Chem 2011,8,245-251","journal-title":"J Chem"},{"key":"ref=6","first-page":"297","volume":"6","author":"Youness Boukharsa Y.Z.","year":"2014","unstructured":"Youness Boukharsa Y.Z.; Taoufik J.; Ansar M.; Pyridazin-3(2H)-ones: Synthesis, reactivity, applications in pharmacology and agriculture. J Chem Pharm Res 2014,6,297-310","journal-title":"J Chem Pharm Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bioorg.2016.03.007","volume":"66","author":"Abbas S.H.","year":"2016","unstructured":"Abbas S.H.; Abuo-Rahma G.E.D.A.A.; Abdel-Aziz M.; Aly O.M.; Beshr E.A.; Gamal-Eldeen A.M.; Synthesis, cytotoxic activity, and tubulin polymerization inhibitory activity of new pyrrol-2(3H)-ones and pyridazin-3(2H)-ones. Bioorg Chem 2016,66,46-62","journal-title":"Bioorg Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21608\/jabps.2018.5283.1023","volume":"2","author":"Abdelbaset M.","year":"2018","unstructured":"Abdelbaset M.; Abdel-Aziz M.; Abuo-Rahma G.; Ramadan M.; Abdelrahman M.; Pyridazinones and pyrrolones as promising Scaffolds in Medicinal Chemistry. J Adv Biomed Pharm Sci 2018,2(1),19-28","journal-title":"J Adv Biomed Pharm Sci"},{"key":"ref=9","first-page":"227","volume":"5","author":"Nieminen M.S.","year":"2013","unstructured":"Nieminen M.S.; Fruhwald S.; Heunks L.M.; Suominen P.K.; Gordon A.C.; Kivikko M.; Pollesello P.; Levosimendan: Current data, clinical use and future development. Heart Lung Vessel 2013,5(4),227-245","journal-title":"Heart Lung Vessel"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s11094-021-02515-9","volume":"55","author":"Alghamdi S.","year":"2021","unstructured":"Alghamdi S.; Imran M.; Kamal M.; Asif M.; Synthesis, characterization and antimycobacterial activity of some substituted phenylpyridazinone derivatives. Pharm Chem J 2021,55(12),1345-1349","journal-title":"Pharm Chem J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1134\/S1068162020050167","volume":"46","author":"Mohd I.","year":"2020","unstructured":"Mohd I.; Mohammad A.; Study of various pyridazine and phthalazine drugs with diverse therapeutical and agrochemical activities. Russ J Bioorganic Chem 2020,46(5),745-767","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/22297928.2020.1776633","volume":"10","author":"Asif M.","year":"2020","unstructured":"Asif M.; Imran M.; Antitubercular and anticonvulsant activities of Phenyl-di-hydropyridazinone derivatives containing 2-Substituted amin-1-yl-methyl and 2-(2- 1H -amin-1-yl) ethyl moieties. Anal Chem Lett 2020,10(3),414-427","journal-title":"Anal Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.bmcl.2010.12.028","volume":"21","author":"Siddiqui A.A.","year":"2011","unstructured":"Siddiqui A.A.; Mishra R.; Shaharyar M.; Husain A.; Rashid M.; Pal P.; Triazole incorporated pyridazinones as a new class of antihypertensive agents: Design, synthesis and in vivo screening. Bioorg Med Chem Lett 2011,21(3),1023-1026","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s00044-009-9232-6","volume":"19","author":"Thota S.","year":"2010","unstructured":"Thota S.; Bansal R.; Synthesis of new pyridazinone derivatives as platelet aggregation inhibitors. Med Chem Res 2010,19(8),808-816","journal-title":"Med Chem Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ddr.21079","volume":"74","author":"Bansal R.","year":"2013","unstructured":"Bansal R.; Kumar D.; Sharma D.; Calle C.; Carron R.; Synthesis and pharmacological evaluation of 6-arylpyridazinones as potent vasorelaxants. Drug Dev Res 2013,74(5),296-305","journal-title":"Drug Dev Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/bkcs.11156","volume":"38","author":"Lee J.","year":"2017","unstructured":"Lee J.; Shin A.Y.; Lee H.S.; Isolation and synthesis of luffariellolide derivatives and evaluation of antibacterial activities against gram-negative bacteria. Bull Korean Chem Soc 2017,38(7),804-807","journal-title":"Bull Korean Chem Soc"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2042-7158.1953.tb13950.x","volume":"5","author":"Asif M.","year":"2011","unstructured":"Asif M.; Singh D.; Singh A.; Analgesic activity of some 6-phenyl-4-substituted benzylidene tetrahydro pyridazin-3(2H)-ones. Glob J Pharmacol 2011,5,18-22","journal-title":"Glob J Pharmacol"},{"key":"ref=18","first-page":"357","volume":"59","author":"G\u00f6k\u00e7e M.","year":"2009","unstructured":"G\u00f6k\u00e7e M.; Colak M.S.; K\u00fcpeli E.; Sahin M.F.; Synthesis and analgesic and anti-inflammatory activity of 6-phenyl\/(4-methylphenyl)-3(2H)-pyridazinon-2-propionamide derivatives. Arzneimittelforschung 2009,59(7),357-363","journal-title":"Arzneimittelforschung"},{"key":"ref=19","first-page":"481485","volume":"9","author":"Asif M.","year":"2011","unstructured":"Asif M.; Singh A.; Anticonvulsant activity of 4-(substituted benzylidene)-6-(3-nitrophenyl)-4,5-dihydro pyridazin-3(2H)-ones against maximal electro shock induced seizure. Middle East J Sci Res 2011,9,481485","journal-title":"Middle East J Sci Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1002\/slct.201800459","volume":"3","author":"Kummari B.","year":"2018","unstructured":"Kummari B.; Ramesh P.; Parsharamulu R.; Allaka T.R.; Anantaraju H.; Yogeeswari P.; Balasubramanian S.; Guggilapu S.D.; Babu B.N.; Anireddy J.S.; Design and synthesis of new Etodolac\u2010Pyridazinones as Potent Anticancer Agents Using Pb(OAc) 4 to assist N\u2010N Bond formation. ChemistrySelect 2018,3(18),5050-5054","journal-title":"ChemistrySelect"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1016\/j.bmcl.2010.09.031","volume":"20","author":"Costas T.","year":"2010","unstructured":"Costas T.; Besada P.; Piras A.; Acevedo L.; Ya\u00f1ez M.; Orallo F.; Laguna R.; Ter\u00e1n C.; New pyridazinone derivatives with vasorelaxant and platelet antiaggregatory activities. Bioorg Med Chem Lett 2010,20(22),6624-6627","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=22","first-page":"248","volume":"3","author":"El-Ghaffar N.A.","year":"2011","unstructured":"El-Ghaffar N.A.; Mohamed M.K.; Kadah M.S.; Radwan A.M.; Said G.H.; Abd S.N.; Synthesis and anti-tumor activities of some new pyridazinones containing the 2-phenyl-1h-indolyl moiety. J Chem Pharm Res 2011,3,248-259","journal-title":"J Chem Pharm Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/619749","author":"El-Hashash M.A.","year":"2014","unstructured":"El-Hashash M.A.; Essawy A.; Sobhy Fawzy A.; Synthesis and antimicrobial activity of some novel heterocyclic candidates via Michael addition involving 4-(4-acetamidophenyl)-4-oxobut-2-enoic acid. Adv Chem 2014,1-10","journal-title":"Adv Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1134\/S1068162020050155","volume":"46","author":"Mohd I.","year":"2020","unstructured":"Mohd I.; Mohammad A.; Biologically active pyridazines and pyridazinone derivatives: A scaffold for the highly functionalized compounds. Russ J Bioorganic Chem 2020,46(5),726-744","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/molecules25092002","volume":"25","author":"Khan A.","year":"2020","unstructured":"Khan A.; Diwan A.; Thabet H.K.; Imran M.; Bakht M.A.; Discovery of novel Pyridazine-based cyclooxygenase-2 inhibitors with a promising gastric safety profile. Molecules 2020,25(9),2002","journal-title":"Molecules"},{"key":"ref=26","first-page":"213","volume":"1","author":"Verma S.K.","year":"2008","unstructured":"Verma S.K.; Irrchhaiya R.; Namdeo K.P.; Singh V.K.; Khurana S.; Singh A.; Synthesis and antimicrobial activity of some pyridazinone derivatives. Biomed Pharmacol J 2008,1,213-218","journal-title":"Biomed Pharmacol J"},{"key":"ref=27","first-page":"353","volume":"65","author":"Islam M.","year":"2008","unstructured":"Islam M.; Siddiqui A.A.; Rajesh R.; Synthesis, antitubercular, antifungal and antibacterial activities of 6-substituted phenyl-2-(3\u2032-substituted phenyl pyridazin-6\u2032-yl)-2,3,4,5-tetrahydropyridazin-3-one. Acta Pol Pharm 2008,65(3),353-362","journal-title":"Acta Pol Pharm"},{"key":"ref=28","first-page":"441","volume":"65","author":"Islam M.","year":"2008","unstructured":"Islam M.; Siddiqui A.A.; Rajesh R.; Bakht A.; Goyal S.; Synthesis and antimicrobial activity of some novel oxadiazole derivatives. Acta Pol Pharm 2008,65(4),441-447","journal-title":"Acta Pol Pharm"},{"key":"ref=29","first-page":"295","volume":"5","author":"Siddiqui A.A.","year":"2009","unstructured":"Siddiqui A.A.; Hasan H.; Islam M.; Synthesis and antitubercular activity of some novel pyridazinone derivatives. J Ultra Chem 2009,5,295-304","journal-title":"J Ultra Chem"},{"key":"ref=30","first-page":"319","volume":"2","author":"Siddiqui A.A.","year":"2010","unstructured":"Siddiqui A.A.; Islam M.; Kumar S.; Synthesis and antituberculostic activity of 5-{3\u2032-oxo-6\u2032-(substitutedphenyl)-2\u2032,3\u2032,4\u2032,5\u2032-tetrahydropyridazin-2\u2032-yl}methyl-2-substituted-1,3,4-oxadiazole. Pharm Lett 2010,2,319-327","journal-title":"Pharm Lett"},{"key":"ref=31","first-page":"555","volume":"67","author":"Islam M.","year":"2010","unstructured":"Islam M.; Siddiqui A.A.; Synthesis, antituberculostatic, antifungal and antibacterial activities of 3-substituted phenyl-6-substituted phenyl-1,2,4-triazolo[4,3-b]pyridazines. Acta Pol Pharm 2010,67(5),555-562","journal-title":"Acta Pol Pharm"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12691\/ajps-2-1-1","volume":"2","author":"Asif M.","year":"2014","unstructured":"Asif M.; Singh A.; Lakshmayya L.; Lakshmayya. In-vivo anticonvulsant and in-vitro antimycobacterial activities of 6-aryl pyridazine-3(2H)-one derivatives. Am J Pharmacol Sci 2014,2(1),1-6","journal-title":"Am J Pharmacol Sci"},{"key":"ref=33","first-page":"129","volume":"5","author":"Mogle P.P.","year":"2014","unstructured":"Mogle P.P.; Kamble R.D.; Hese S.V.; Hebade M.J.; More R.A.; Kamble S.S.; Gacche R.N.; Dawane B.S.; Synthesis of new dihydropyridazin-3(2H)-ylidene)hydrazine carbothioamide derivatives as an antituberculosis agent. Chemica Sinica 2014,5,129-134","journal-title":"Chemica Sinica"},{"key":"ref=34","first-page":"27","volume":"5","author":"Islam M.","year":"2013","unstructured":"Islam M.; Aljaiyash A.A.H.; Synthesis, antifungal and antibacterial activities of 3-substituted phenyl-6-substituted phenyl-(1,2,4)-triazolo[4,3-b]pyridazines. Pharm Lett 2013,5,27-34","journal-title":"Pharm Lett"},{"key":"ref=35","first-page":"1586","volume":"8","author":"Alam M.","year":"2014","unstructured":"Alam M.; Zaman M.S.; Alam M.M.; Husain A.; Studies on 3,5-disubstituted-phenyl-3,3a,4,7-tetrahydro-2H-pyrazolo[3,4-c]pyridazine derivatives. J Pharm Res 2014,8,1586-1591","journal-title":"J Pharm Res"},{"key":"ref=36","first-page":"40","volume":"93","author":"Kandi N.G.","year":"1996","unstructured":"Kandi N.G.; Mohamed M.I.; Zaky H.T.; Mohamed M.S.; New pyridazine derivatives. Effects on a biological system. Tinctoria 1996,93,40-49","journal-title":"Tinctoria"},{"key":"ref=37","first-page":"1524","volume":"4","author":"Budhlakoti P.","year":"2013","unstructured":"Budhlakoti P.; Kumar Y.; Verma A.; Alok S.; Synthesis, antibacterial activity, and molecular properties prediction of some pyridazine-3-one derivatives. Int J Pharm Sci Res 2013,4,1524-1528","journal-title":"Int J Pharm Sci Res"},{"key":"ref=38","first-page":"223","volume":"65","author":"Siddiqui A.A.","year":"2008","unstructured":"Siddiqui A.A.; Ahamad S.R.; Mir M.S.; Hussain S.A.; Raish M.; Kaur R.; Synthesis and in-vitro antifungal activity of 6-substituted-phenyl-2-{[(4\u2032-substituted phenyl-5\u2032-thioxo)-1,2,4-triazol-3-yl]-methyl}-2,3,4,5-tetrahydropyridazin-3-one derivatives. Acta Pol Pharm 2008,65,223-228","journal-title":"Acta Pol Pharm"},{"key":"ref=39","first-page":"228","volume":"3","author":"Siddiqui A.A.","year":"2011","unstructured":"Siddiqui A.A.; Hasan H.M.I.; Islam M.; Antifungal potential of 1,2-4triazole derivatives and therapeutic efficacy of Tineacorporis in albino rats. Pharm Lett 2011,3,228-236","journal-title":"Pharm Lett"},{"key":"ref=40","first-page":"624","volume":"6","author":"Islam M.","year":"2016","unstructured":"Islam M.; Albratty M.; Antiviral activity of some novel synthesized 1,3,4-oxadiazoles. J Chem Biol Phys Sci 2016,6,624-633","journal-title":"J Chem Biol Phys Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1515\/znc-2012-5-604","volume":"67","author":"Sukuroglu M.","year":"2012","unstructured":"Sukuroglu M.; Onkol T.; Onurda\u011f F.K.; Akal\u0131n G.; \u015eahin M.F.; Synthesis and in vitro biological activity of new 4,6-disubstituted 3(2H)-pyridazinone-acetohydrazide derivatives. Z Naturforsch C J Biosci 2012,67(5-6),257-265","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=42","first-page":"469","volume":"32","author":"Do\u011fruer D.S.","year":"2008","unstructured":"Do\u011fruer D.S.; \u00d6nkol T.; \u00d6zkan S.; Oezgen S.; \u0120 ah\u0121n M.F.; Synthesis and antimicrobial activity of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives. Turk J Chem 2008,32,469-479","journal-title":"Turk J Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1021\/jf0201677","volume":"50","author":"Zou X.J.","year":"2002","unstructured":"Zou X.J.; Lai L.H.; Jin G.Y.; Zhang Z.X.; Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles. J Agric Food Chem 2002,50(13),3757-3760","journal-title":"J Agric Food Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejmech.2005.10.003","volume":"41","author":"S\u00f6nmez M.","year":"2006","unstructured":"S\u00f6nmez M.; Berber I.; Akba\u015f E.; Synthesis, antibacterial and antifungal activity of some new pyridazinone metal complexes. Eur J Med Chem 2006,41(1),101-105","journal-title":"Eur J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4067\/S0717-97072011000300013","volume":"56","author":"Husain A.","year":"2011","unstructured":"Husain A.; Ahmad A.; Bhandari A.; Ram V.; Synthesis and antitubercular activity of pyridazinone derivatives. J Chil Chem Soc 2011,56(3),778-780","journal-title":"J Chil Chem Soc"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3906\/kim-1009-63","volume":"35","author":"Utku S.","year":"2011","unstructured":"Utku S.; G\u00f6k\u00e7e M.; Aslan G.; Bayram G.; \u00dclger M.; Emekda\u015f G.; \u015eahi\u0307n M.F.; Synthesis and in vitro antimycobacterial activities of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted\/nonsubstituted acetophenone) hydrazone. Turk J Chem 2011,35,331-339","journal-title":"Turk J Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"37092","DOI":"10.1039\/C9RA08954C","volume":"9","author":"Lien V.T.","year":"2019","unstructured":"Lien V.T.; Kristiansen M.K.; Pettersen S.; Haugen M.H.; Olberg D.E.; Waaler J.; Klaveness J.; Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation. RSC Advances 2019,9(63),37092-37100","journal-title":"RSC Advances"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejmech.2016.01.048","volume":"112","author":"George R.F.","year":"2016","unstructured":"George R.F.; Fouad M.A.; Gomaa I.E.O.; Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers. Eur J Med Chem 2016,112,48-59","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ejmech.2015.12.015","volume":"108","author":"George R.F.","year":"2016","unstructured":"George R.F.; Saleh D.O.; Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives. Eur J Med Chem 2016,108,663-673","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1021\/jm00025a004","volume":"38","author":"Combs D.W.","year":"1995","unstructured":"Combs D.W.; Reese K.; Cornelius L.A.M.; Gunnet J.W.; Cryan E.V.; Granger K.S.; Jordan J.J.; Demarest K.T.; Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors. J Med Chem 1995,38(25),4880-4884","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF03247219","volume":"3","author":"Rakib E.M.","year":"2006","unstructured":"Rakib E.M.; Abouricha S.; Hannioui A.; Benchat N.; Ait-M\u2019barek L.; Zyad A.; Synthesis and in vitro cytotoxicity studies of novel triazolo[4,3-b]pyridazinones. J Iran Chem Soc 2006,3,272-276","journal-title":"J Iran Chem Soc"},{"key":"ref=52","first-page":"40","volume":"3","author":"Asif M.","year":"2013","unstructured":"Asif M.; Acharya M.; Lakshmayya, Singh, A. Bioactivity of 6-aryl-4,5-dihydropyridazin-3(2H)-ones using brine shrimp (Artemia salina) lethality assay. Int J Pharm Chem 2013,3,40-44","journal-title":"Int J Pharm Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1016\/j.ejmech.2010.09.029","volume":"45","author":"Al-Tel T.H.","year":"2010","unstructured":"Al-Tel T.H.; Design and synthesis of novel tetrahydro-2H-Pyrano[3,2-c]Pyridazin-3(6H)-one derivatives as potential anticancer agents. Eur J Med Chem 2010,45(12),5724-5731","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/molecules14093494","volume":"14","author":"Pau A.","year":"2009","unstructured":"Pau A.; Murineddu G.; Asproni B.; Murruzzu C.; Grella G.; Pinna G.; Curzu M.; Marchesi I.; Bagella L.; Synthesis and cytotoxicity of novel hexahydrothienocycloheptapyridazinone derivatives. Molecules 2009,14(9),3494-3508","journal-title":"Molecules"},{"key":"ref=55","first-page":"1","author":"Selvakumar P.","year":"2014","unstructured":"Selvakumar P.; Thennarasu S.; Mandal A.B.; Synthesis of novel pyridopyridazin-3(2H)-one derivatives and evaluation of their cytotoxic activity against mcf-7 cells. ISRN Org Chem 2014,1-7","journal-title":"ISRN Org Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ejmech.2015.11.042","volume":"108","author":"Liu Y.","year":"2016","unstructured":"Liu Y.; Jin S.; Peng X.; Lu D.; Zeng L.; Sun Y.; Ai J.; Geng M.; Hu Y.; Pyridazinone derivatives displaying highly potent and selective inhibitory activities against c-Met tyrosine kinase. Eur J Med Chem 2016,108,322-333","journal-title":"Eur J Med Chem"},{"key":"ref=57","first-page":"27","volume":"1","author":"Xu P.","year":"1992","unstructured":"Xu P.; Wang S.; Liu W.; Synthesis, anticonvulsant activity, and the structure-activity relationships of phenyl pyridazinones and their GABA derivatives. J Chin Pharm Sci 1992,1,27-34","journal-title":"J Chin Pharm Sci"},{"key":"ref=58","first-page":"656","volume":"26","author":"Xu P.","year":"1991","unstructured":"Xu P.; Wang S.Y.; Chen Y.; Liu W.Q.; Tao C.; Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones. Yao Xue Xue Bao 1991,26(9),656-660","journal-title":"Yao Xue Xue Bao"},{"key":"ref=59","first-page":"42","volume":"1","author":"Xu P.","year":"1990","unstructured":"Xu P.; Wang S.; Zhang C.; Liang H.; Liu W.; Synthesis and anticonvulsant activity of 6-aryl-3-(4-methylpiperazinyl) pyridazines. Zhongguo Yaowu Huaxue Zazhi 1990,1,42-48","journal-title":"Zhongguo Yaowu Huaxue Zazhi"},{"key":"ref=60","first-page":"249","volume":"47","author":"Kane J.M.","year":"1992","unstructured":"Kane J.M.; Huber E.W.; Miller F.P.; Kehne J.H.; Synthesis and pharmacology of 3-aryl-5,6-dihydro-6-oxo-1(4H)-pyridazineacetic acid derivatives. Pharmazie 1992,47(4),249-251","journal-title":"Pharmazie"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/jm9805889","volume":"42","author":"Rybczynski P.J.","year":"1999","unstructured":"Rybczynski P.J.; Combs D.W.; Jacobs K.; Shank R.P.; Dubinsky B.; \u03b3 -Aminobutyrate-A Receptor Modulation by 3-Aryl-1-(arylsulfonyl)- 1,4,5,6-tetrahydropyridazines. J Med Chem 1999,42(13),2403-2408","journal-title":"J Med Chem"},{"key":"ref=62","first-page":"303","volume":"20","author":"Siddiqui A.A.","year":"2004","unstructured":"Siddiqui A.A.; Shahroz M.M.; Amir M.; Synthesis and anticonvulsant activity of 6-(substituted aryl)-2,3,4,5-tetrahydro-3-pyridazinones. Orient J Chem 2004,20,303-306","journal-title":"Orient J Chem"},{"key":"ref=63","first-page":"65","volume":"4","author":"Siddiqui A.A.","year":"2008","unstructured":"Siddiqui A.A.; Sharma B.; Namdev K.P.; Chauhan D.; Synthesis and anticonvulsant activity of [6-oxo-3-(substituted phenyl)-5,6-dihydro-4H-pyridazine-1-yl]acetic acid hydrazide. J Ultra Chem 2008,4,65-70","journal-title":"J Ultra Chem"},{"key":"ref=64","first-page":"97","volume":"81","author":"Namdeo K.P.","year":"2009","unstructured":"Namdeo K.P.; Abdullah M.M.; Sidhquee A.A.; Synthesis and anti-convulsant activity of some N,N\u2032-substituted arylmethane-dipyridazinones. J. Institutional Chemists 2009,81,97-101","journal-title":"Institutional Chemists"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00044-013-0618-0","volume":"23","author":"Sharma B.","year":"2014","unstructured":"Sharma B.; Verma A.; Sharma U.K.; Prajapati S.; Efficient synthesis, anticonvulsant and muscle relaxant activities of new 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives. Med Chem Res 2014,23(1),146-157","journal-title":"Med Chem Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1700135","DOI":"10.1002\/ardp.201700135","volume":"350","author":"Partap S.","year":"2017","unstructured":"Partap S.; Yar M.S.; Hassan M.Z.; Akhtar M.J.; Siddiqui A.A.; Design, synthesis, and pharmacological screening of pyridazinone hy-brids as anticonvulsant agents. Arch Pharm 2017,350(10),1700135","journal-title":"Arch Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioorg.2018.01.001","volume":"77","author":"Partap S.","year":"2018","unstructured":"Partap S.; Akhtar M.J.; Yar M.S.; Hassan M.Z.; Siddiqui A.A.; Pyridazinone hybrids: Design, synthesis and evaluation as potential anti-convulsant agents. Bioorg Chem 2018,77,74-83","journal-title":"Bioorg Chem"},{"key":"ref=68","first-page":"522","volume":"1","author":"Banerjee P.","year":"2009","unstructured":"Banerjee P.; Sharma P.; Nema R.; Synthesis and anticonvulsant activity of pyridazinone derivatives. Int J Chemtech Res 2009,1,522-525","journal-title":"Int J Chemtech Res"},{"key":"ref=69","first-page":"15","volume":"1","author":"Husain A.","year":"2015","unstructured":"Husain A.; Khokra S.; Thakur P.; Choudhary D.; Kohli S.; Ahmad A.; Khan S.; Molecular modeling and in silico evaluation of novel pyridazinones derivatives as anticonvulsant agents. J Insilico and In-vitro Pharmacol 2015,1,15","journal-title":"J Insilico and In-vitro Pharmacol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2174\/1570180811310070013","volume":"10","author":"Asif M.","year":"2013","unstructured":"Asif M.; Singh A.; Lakshmayya, ; Husain A.; Siddiqui A.A.; Anticonvulsant and antitubercular activities of 6-phenyl\/biphenyl-4-yl-2-[2-(pyridin-2-ylamino)-ethyl]- and 6-(biphenyl-4yl)-2-(2N-substituted amin-1-yl)-ethyl derivatives of 4,5-dihydropyridazin-3(2H)-one. Lett Drug Des Discov 2013,10,651-660","journal-title":"Lett Drug Des Discov"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00044-009-9218-4","volume":"19","author":"Abouzid K.A.M.","year":"2010","unstructured":"Abouzid K.A.M.; Khalil N.A.; Ahmed E.M.; El-Latif H.A.A.; El-Araby M.E.; Structure-based molecular design, synthesis, and in vivo anti-inflammatory activity of pyridazinone derivatives as nonclassic COX-2 inhibitors. Med Chem Res 2010,19(7),629-642","journal-title":"Med Chem Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1016\/j.bmc.2008.04.007","volume":"16","author":"Abouzid K.","year":"2008","unstructured":"Abouzid K.; Bekhit S.A.; Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity. Bioorg Med Chem 2008,16(10),5547-5556","journal-title":"Bioorg Med Chem"},{"key":"ref=73","first-page":"727","volume":"27","author":"Do\u011fruer D.S.","year":"2003","unstructured":"Do\u011fruer D.S.; \u0120 ah\u0121n M.F.; K\u00fcpeli E.; Ye\u0121lada E.; Synthesis and analgesic and anti-inflammatory activity of new pyridazinones. Turk J Chem 2003,27,727-738","journal-title":"Turk J Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ardp.200300778","volume":"336","author":"\u00d6k\u00e7elik B.","year":"2003","unstructured":"\u00d6k\u00e7elik B.; \u00dcnl\u00fc S.; Banoglu E.; K\u00fcpeli E.; Ye\u015filada E.; \u015eahin M.F.; Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity. Arch Pharm 2003,336(9),406-412","journal-title":"Arch Pharm"},{"key":"ref=75","first-page":"111","volume":"37","author":"\u00d6zdemir Z.","year":"2012","unstructured":"\u00d6zdemir Z.; G\u00f6k\u00e7e M.; Karakurt A.; Synthesis and analgesic antiinflammatory and antimicrobial evaluation of 6 substituted 3(2H)pyridazinone-2-acetyl-2-substituted benzal hydrazone derivatives. FABAD J Pharm Sci 2012,37,111-122","journal-title":"FABAD J Pharm Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s12272-012-1205-5","volume":"35","author":"Saeed M.M.","year":"2012","unstructured":"Saeed M.M.; Khalil N.A.; Ahmed E.M.; Eissa K.I.; Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents. Arch Pharm Res 2012,35(12),2077-2092","journal-title":"Arch Pharm Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.035","volume":"146","author":"Barberot C.","year":"2018","unstructured":"Barberot C.; Moniot A.; Allart-Simon I.; Malleret L.; Yegorova T.; Laronze-Cochard M.; Bentaher A.; M\u00e9debielle M.; Bouillon J.P.; H\u00e9non E.; Sapi J.; Velard F.; G\u00e9rard S.; Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents. Eur J Med Chem 2018,146,139-146","journal-title":"Eur J Med Chem"},{"key":"ref=78","first-page":"1125","volume":"8","author":"Rama K.","year":"2016","unstructured":"Rama K.; Sumakanth M.; Anupama S.P.; Synthesis and docking studies of novel series of 7-(o-triazolo pyridazin-3yl)-4-methyl coumarins. J Chem Pharm Res 2016,8,1125-1135","journal-title":"J Chem Pharm Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/1570180811310060006","volume":"10","author":"Sukuroglu M.","year":"2013","unstructured":"Sukuroglu M.; Yamali C.; Tiryaki D.; Onurdag F.K.; Akkol E.; Dogruer D.S.; Synthesis of some new 3(2H)-pyridazinone derivatives and evaluation of their analgesic-anti-inflammatory and antimicrobial activities. Lett Drug Des Discov 2013,10(6),507-514","journal-title":"Lett Drug Des Discov"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3906\/kim-1111-29","volume":"36","author":"Bayta\u015f S.","year":"2012","unstructured":"Bayta\u015f S.; \u0130nceler N.; Mavaneh K.F.; Uluda\u011f M.O.; Abacio\u011flu N.; G\u00f6k\u00e7e M.; Synthesis of antipyrine\/pyridazinone hybrids and investigation of their in vivo analgesic and anti-inflammatory activities. Turk J Chem 2012,36,734-748","journal-title":"Turk J Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00044-012-0253-1","volume":"22","author":"Tiryaki D.","year":"2013","unstructured":"Tiryaki D.; Sukuroglu M.; Dogruer D.S.; Akkol E.; Ozgen S.; Sahin M.F.; Synthesis of some new 2,6-disubstituted-3(2H)-pyridazinone derivatives and investigation of their analgesic, anti-inflammatory and antimicrobial activities. Med Chem Res 2013,22(6),2553-2560","journal-title":"Med Chem Res"},{"key":"ref=82","first-page":"166","volume":"6","author":"Sumakanth M.","year":"2007","unstructured":"Sumakanth M.; Malla Reddy V.; Krishnan V.S.H.; Sastry B.S.; Synthesis and pharmacological evaluation of new 2,6-disubstituted-2H-pyridazin-3-ones. J Pharm Res 2007,6,166-169","journal-title":"J Pharm Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1016\/j.bmcl.2009.07.075","volume":"19","author":"K\u00fcmmerle A.E.","year":"2009","unstructured":"K\u00fcmmerle A.E.; Vieira M.M.; Schmitt M.; Miranda A.L.P.; Fraga C.A.M.; Bourguignon J.J.; Barreiro E.J.; Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones (NAH). Bioorg Med Chem Lett 2009,19(17),4963-4966","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0960-894X(00)80512-0","volume":"2","author":"Brooks D.W.","year":"1992","unstructured":"Brooks D.W.; Basha A.; Kerdesky F.A.J.; Holms J.H.; Ratajcyk J.D.; Bhatia P.; Moore J.L.; Martin J.G.; Schmidt S.P.; Albert D.H.; Dyer R.D.; Young P.; Carter G.W.; Structure-activity relationships of the pyridazinone series of 5-lipoxygenase inhibitors. Bioorg Med Chem Lett 1992,2(11),1357-1360","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ejmech.2013.03.066","volume":"64","author":"Giovannoni M.P.","year":"2013","unstructured":"Giovannoni M.P.; Schepetkin I.A.; Cilibrizzi A.; Crocetti L.; Khlebnikov A.I.; Dahlgren C.; Graziano A.; Dal Piaz V.; Kirpotina L.N.; Zerbinati S.; Vergelli C.; Quinn M.T.; Further studies on 2-arylacetamide pyridazin-3(2H)-ones: Design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. Eur J Med Chem 2013,64,512-528","journal-title":"Eur J Med Chem"},{"key":"ref=86","first-page":"614","volume":"39B","author":"Khan M.S.Y.","year":"2000","unstructured":"Khan M.S.Y.; Siddiqui A.A.; Syntheses and antiinflammatory activity of some 6-aryl -2,3,4,5-tetrahydro-3-pyridazinones. Ind J Chem, Sec B 2000,39B,614-619","journal-title":"Ind J Chem, Sec B"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1021\/jm900458r","volume":"52","author":"Biancalani C.","year":"2009","unstructured":"Biancalani C.; Giovannoni M.P.; Pieretti S.; Cesari N.; Graziano A.; Vergelli C.; Cilibrizzi A.; Di Gianuario A.; Colucci M.; Mangano G.; Garrone B.; Polenzani L.; Dal Piaz V.; Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. J Med Chem 2009,52(23),7397-7409","journal-title":"J Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1590\/S1984-82502013000400030","volume":"49","author":"Singh A.","year":"2013","unstructured":"Singh A.; Asif M.; Analgesic and anti-inflammatory activities of several 4-substituted-6-(3\u2032-nitrophenyl)pyridazin-(2H)-3-one deriva-tives. Braz J Pharm Sci 2013,49(4),903-909","journal-title":"Braz J Pharm Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF02977751","volume":"28","author":"S\u00fck\u00fcroglu M.","year":"2005","unstructured":"S\u00fck\u00fcroglu M.; Erg\u00fcn B.\u00c7.; \u00fcnl\u00fc S.; Sahin M.F.; K\u00fcpeli E.; Yesilada E.; Banoglu E.; Synthesis, analgesic, and anti-inflammatory activities of [6-(3,5-dimethyl-4-chloropyrazole-1-yl)-3(2H)-pyridazinon-2-yl]acetamides. Arch Pharm Res 2005,28(5),509-517","journal-title":"Arch Pharm Res"},{"key":"ref=90","first-page":"257","volume":"13","author":"Siddiqui A.A.","year":"2004","unstructured":"Siddiqui A.A.; Kushnoor A.; Wani S.M.; Synthesis and antiinflammatory activity of 6-(substituted-aryl)-2,3,4,5-tetrahydro-3-thiopyridazinones. Indian J Heterocycl Chem 2004,13,257-260","journal-title":"Indian J Heterocycl Chem"},{"key":"ref=91","first-page":"59","volume":"21","author":"Bondar K.V.","year":"2016","unstructured":"Bondar K.V.; Klimenko K.O.; Alexandrova O.I.; Kravchenko I.A.; Schepetkin I.A.; Lyakhov S.A.; Indeno[1,2,3-de]phthalazin-3(2H)-one and its analogs-synthesis and antiinflammatory properties. Visnik Odes\u2019koho Natsional\u2019noho Universitetu. Khimiya 2016,21,59-71","journal-title":"Khimiya"},{"key":"ref=92","first-page":"644","volume":"1974","author":"Pitarch L.","year":"1974","unstructured":"Pitarch L.; Coronas R.; Mallol J.; Chemical and pharmacological study of a series of substituted pyridazones. Eur J Med Chem 1974,1974(9),644-650","journal-title":"Eur J Med Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4155\/fmc-2019-0160","volume":"12","author":"Allam H.A.","year":"2020","unstructured":"Allam H.A.; Kamel A.A.; El-Daly M.; George R.F.; Synthesis and vasodilator activity of some pyridazin-3(2 H)-one based compounds. Future Med Chem 2020,12(1),37-50","journal-title":"Future Med Chem"},{"key":"ref=94","first-page":"6491","volume":"21","author":"Jha K.K.","year":"2009","unstructured":"Jha K.K.; Kumar Y.; Shaharyar M.; Sharma G.J.; Microwave assisted synthesis, characterization and pharmacological evaluation of pyridazinone derivatives. Asian J Chem 2009,21,6491-6496","journal-title":"Asian J Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/jm00249a004","volume":"17","author":"Curran W.V.","year":"1974","unstructured":"Curran W.V.; Ross A.; 6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. Series of hypotensive agents. J Med Chem 1974,17(3),273-281","journal-title":"J Med Chem"},{"key":"ref=96","first-page":"1179","volume":"25","author":"Shatalov G.V.","year":"1982","unstructured":"Shatalov G.V.; Gridchin S.A.; Kovalev G.V.; Mikhant\u2019ev B.I.; Gofman S.M.; Allylation of compounds containing a pyridazine ring. Izvestiya Vysshikh Uchebnykh Zavedenii. Khimiyai Khimicheskaya Tekhnologiya 1982,25,1179-1184","journal-title":"Khimiyai Khimicheskaya Tekhnologiya"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/jm00397a033","volume":"31","author":"Robertson D.W.","year":"1988","unstructured":"Robertson D.W.; Krushinski J.H.; Pollock G.D.; Hayes J.S.; Imidazole-pyridine bioisosterism: Comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydro-pyridazinone cardiotonics. J Med Chem 1988,31(2),461-465","journal-title":"J Med Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0223-5234(92)90098-L","volume":"27","author":"M\u00e1tyus P.","year":"1992","unstructured":"M\u00e1tyus P.; Kos\u00e1ry J.; Kasztreiner E.; Makk N.; Diesler E.; Czak\u00f3 K.; Rabloczky G.; Jaszlits L.; Horv\u00e1th E.; T\u00f6m\u00f6sk\u00f6zi Z.; Cseh G.; Horv\u00e1th E.; Ar\u00e1nyi P.; Synthesis, antihypertensive and \u03b1-adrenoceptor activity of novel 2-aminoalkyl-3(2H)-pyridazinones. Eur J Med Chem 1992,27(2),107-114","journal-title":"Eur J Med Chem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.ejmech.2010.02.003","volume":"45","author":"Siddiqui A.A.","year":"2010","unstructured":"Siddiqui A.A.; Mishra R.; Shaharyar M.; Synthesis, characterization and antihypertensive activity of pyridazinone derivatives. Eur J Med Chem 2010,45(6),2283-2290","journal-title":"Eur J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3109\/14756366.2012.656623","volume":"28","author":"Mishra R.","year":"2013","unstructured":"Mishra R.; Siddiqui A.A.; Husain A.; Rashid M.; Goda C.; Design, synthesis and antihypertensive screening of novel pyridazine substituted s-triazin-2-imine\/one\/thione derivatives. J Enzyme Inhib Med Chem 2013,28(3),552-559","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1211\/0022357043905","volume":"56","author":"Gouault N.","year":"2010","unstructured":"Gouault N.; Martin-Chouly C.A.E.; Lugnier C.; Cupif J.F.; Tonnelier A.; Feger F.; Lagente V.; David M.; Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents. J Pharm Pharmacol 2010,56(8),1029-1037","journal-title":"J Pharm Pharmacol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"267","DOI":"10.13005\/ojc\/320129","volume":"32","author":"Imran M.","year":"2016","unstructured":"Imran M.; Nayeem N.; Synthesis and antihypertensive activity of some novel pyridazinones. Orient J Chem 2016,32(1),267-274","journal-title":"Orient J Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bmc.2007.09.031","volume":"16","author":"Abouzid K.","year":"2008","unstructured":"Abouzid K.; Abdel Hakeem M.; Khalil O.; Maklad Y.; Pyridazinone derivatives: Design, synthesis, and in vitro vasorelaxant activity. Bioorg Med Chem 2008,16(1),382-389","journal-title":"Bioorg Med Chem"},{"key":"ref=104","first-page":"856","volume":"56","author":"Mishra R.","year":"2011","unstructured":"Mishra R.; Siddiqui A.A.; Husain A.; Rashid M.; Prakash A.; Tailang M.; Kumar M.; Srivastava N.; Synthesis, characterization and antihypertensive activity of some new substituted pyridazine derivatives. J. Chelian. Chem Soc 2011,56,856-859","journal-title":"Chem Soc"},{"key":"ref=105","first-page":"2","volume":"2","author":"Jakhmola V.","year":"2018","unstructured":"Jakhmola V.; Jawla S.; Mishra R.; Synthesis, characterization and antihypertensive activity of 4,5 dihydropyridazin-3(2H)-one derivatives. Acta Sci Pharm Sci 2018,2,2-7","journal-title":"Acta Sci Pharm Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/S0968-0896(02)00146-3","volume":"10","author":"Sotelo E.","year":"2002","unstructured":"Sotelo E.; Fraiz N.; Y\u00e1\u00f1ez M.; Terrades V.; Laguna R.; Cano E.; Ravi\u00f1a E.; Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions. Bioorg Med Chem 2002,10(9),2873-2882","journal-title":"Bioorg Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1248\/cpb.45.1151","volume":"45","author":"Laguna R.","year":"1997","unstructured":"Laguna R.; Rodriguez-Linared B.; Cano E.; Estevez I.; Ravi\u00f1a E.; Sotelo E.; Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors. Chem Pharm Bull 1997,45(7),1151-1155","journal-title":"Chem Pharm Bull"},{"key":"ref=108","first-page":"209","volume":"18","author":"Yamada T.","year":"1983","unstructured":"Yamada T.; Tsukamoto Y.; Shimamura H.; Banno S.; Sato M.; Pyridazinones I.V.; Synthesis, antisecretory and antiulcer activities of urea derivatives. Eur J Med Chem 1983,18,209-214","journal-title":"Eur J Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1021\/jm00362a011","volume":"26","author":"Yamada T.","year":"1983","unstructured":"Yamada T.; Shimamura H.; Tsukamoto Y.; Yamaguchi A.; Ohki M.; Pyridazinones. 3. Synthesis, antisecretory, and antiulcer activities of 2-cyanoguanidine derivatives. J Med Chem 1983,26(8),1144-1149","journal-title":"J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/jm00357a012","volume":"26","author":"Yamada T.","year":"1983","unstructured":"Yamada T.; Nobuhara Y.; Shimamura H.; Tsukamoto Y.; Yoshihara K.; Yamaguchi A.; Ohki M.; Pyridazinones. 2. Synthesis and antisecretory and antiulcer activities of thiourea and 2-cyanoguanidine derivatives. J Med Chem 1983,26(3),373-381","journal-title":"J Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1021\/jm00350a018","volume":"25","author":"Yamada T.","year":"1982","unstructured":"Yamada T.; Nobuhara Y.; Yamaguchi A.; Ohki M.; Pyridazinones. 1. Synthesis, antisecretory, and antiulcer activities of thio amide derivatives. J Med Chem 1982,25(8),975-982","journal-title":"J Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00044-014-1205-8","volume":"24","author":"Yamal\u0131 C.","year":"2015","unstructured":"Yamal\u0131 C.; Ozan G\u00fclcan H.; Kahya B.; \u00c7obano\u011flu S.; Kadir \u015e\u00fck\u00fcro\u011flu M.; Do\u011fruer D.S.; Synthesis of some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities. Med Chem Res 2015,24(3),1210-1217","journal-title":"Med Chem Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejmech.2013.01.056","volume":"63","author":"Xing W.","year":"2013","unstructured":"Xing W.; Fu Y.; Shi Z.; Lu D.; Zhang H.; Hu Y.; Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors. Eur J Med Chem 2013,63,95-103","journal-title":"Eur J Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1021\/jm981101z","volume":"42","author":"Contreras J.M.","year":"1999","unstructured":"Contreras J.M.; Rival Y.M.; Chayer S.; Bourguignon J.J.; Wermuth C.G.; Aminopyridazines as acetylcholinesterase inhibitors. J Med Chem 1999,42(4),730-741","journal-title":"J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jhet.5570420306","volume":"42","author":"Gelain A.","year":"2005","unstructured":"Gelain A.; Pyridazine derivatives as novel acyl-coa:cholesterol acyltransferase (acat) inhibitors. J Heterocycl Chem 2005,42(3),395-400","journal-title":"J Heterocycl Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"7708","DOI":"10.1021\/jm050703x","volume":"48","author":"Gelain A.","year":"2005","unstructured":"Gelain A.; Bettinelli I.; Barlocco D.; Kwon B.M.; Jeong T.S.; Cho K.H.; Toma L.; Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N\u2032-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitors. J Med Chem 2005,48(24),7708-7713","journal-title":"J Med Chem"},{"key":"ref=117","first-page":"55","volume":"6","author":"\u00d6nkol T.","year":"2013","unstructured":"\u00d6nkol T.; G\u00f6k\u00e7e M.; Orhan \u0120.; Kaynak F.; Design, synthesis and evaluation of some novel 3(2H)-pyridazinone-2-yl acetohydrazides as acetylcholinesterase and butyryl-cholnesterase inhibitors. Org Comm 2013,6,55","journal-title":"Org Comm"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/jm9705418","volume":"41","author":"Rival Y.","year":"1998","unstructured":"Rival Y.; Hoffmann R.; Didier B.; Rybaltchenko V.; Bourguignon J.J.; Wermuth C.G.; 5-HT3 antagonists derived from amino-pyridazine-type muscarinic M1 agonists. J Med Chem 1998,41(3),311-317","journal-title":"J Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0223-5234(97)89086-1","volume":"32","author":"Corsano S.","year":"1997","unstructured":"Corsano S.; Strappaghetti G.; Leonardi A.; Rhazri K.; Barbaro R.; New 3(2H)-pyridazinone derivatives: Synthesis and affinity towards \u03b11AR subtypes and 5HT1A receptors. Eur J Med Chem 1997,32(4),339-342","journal-title":"Eur J Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0968-0896(00)00271-6","volume":"9","author":"Strappaghetti G.","year":"2001","unstructured":"Strappaghetti G.; Corsano S.; Barbaro R.; Giannaccini G.; Betti L.; Structure\u2013activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists. Bioorg Med Chem 2001,9(3),575-583","journal-title":"Bioorg Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/ALN.0000000000000505","volume":"122","author":"McKinstry-Wu A.R.","year":"2015","unstructured":"McKinstry-Wu A.R.; Bu W.; Rai G.; Lea W.A.; Weiser B.P.; Liang D.F.; Simeonov A.; Jadhav A.; Maloney D.J.; Eckenhoff R.G.; Discovery of a novel general anesthetic chemotype using high-throughput screening. Anesthesiology 2015,122(2),325-333","journal-title":"Anesthesiology"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.bmcl.2013.12.118","volume":"24","author":"Namoto K.","year":"2014","unstructured":"Namoto K.; Sirockin F.; Ostermann N.; Gessier F.; Flohr S.; Sedrani R.; Gerhartz B.; Trappe J.; Hassiepen U.; Duttaroy A.; Ferreira S.; Sutton J.M.; Clark D.E.; Fenton G.; Beswick M.; Baeschlin D.K.; Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV. Bioorg Med Chem Lett 2014,24(3),731-736","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1016\/j.bmcl.2011.08.009","volume":"21","author":"Xing X.","year":"2011","unstructured":"Xing X.; Chang L.C.; Kong Q.; Colton C.K.; Lai L.; Glicksman M.A.; Lin C.L.G.; Cuny G.D.; Structure\u2013activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators. Bioorg Med Chem Lett 2011,21(19),5774-5777","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2478\/v1007-008-0021-4","volume":"58","author":"Kumar D.","year":"2008","unstructured":"Kumar D.; Carron R.; La Calle C.; Jindal D.; Bansal R.; Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators. Acta Pharm 2008,58(4),393-405","journal-title":"Acta Pharm"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/1475636021000008494","volume":"17","author":"Piaz V.D.","year":"2002","unstructured":"Piaz V.D.; Castellana M.C.; Vergelli C.; Giovannoni M.P.; Gavald\u00e0 A.; Segarra V.; Beleta J.; Ryder H.; Palacios J.M.; Synthesis and evaluation of some pyrazolo[3,4-d]pyridazinones and analogues as PDE 5 inhibitors potentially useful as peripheral vasodilator agents. J Enzyme Inhib Med Chem 2002,17(4),227-233","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejmech.2019.05.026","volume":"177","author":"Bollenbach M.","year":"2019","unstructured":"Bollenbach M.; Lugnier C.; Kremer M.; Salvat E.; Megat S.; Bihel F.; Bourguignon J.J.; Barrot M.; Schmitt M.; Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: Anti-allodynic effect against neuropathic pain in a mouse model. Eur J Med Chem 2019,177,269-290","journal-title":"Eur J Med Chem"},{"key":"ref=127","first-page":"209","volume":"19","author":"Kilian U.","year":"1985","unstructured":"Kilian U.; Amschler H.; Beume R.; Eltze M.; Kolassa N.; Schudt C.; Bronchospasmolytic effects of substituted 6-phenyl-3 [2H]-pyridazinones in comparison to theophylline and enprofylline. Curr Clin Prac Series 1985,19,209-213","journal-title":"Curr Clin Prac Series"},{"key":"ref=128","first-page":"1","author":"Javed T.","year":"2002","unstructured":"Javed T.; Baker N.R.; The role of cAMP and structure-activity relationships of phosphodiesterase inhibitors in cardiac muscle contraction. Pharmacol Aspects Cardiovasc Med 2002,1-14","journal-title":"Pharmacol Aspects Cardiovasc Med"},{"key":"ref=129","first-page":"57","volume":"31","author":"Asif M.","year":"2021","unstructured":"Asif M.; Imran M.; Kamal M.; Acharya M.; Brine Shrimp (Artemia salina) lethality bioassay of some 2-(alkyl\/aryl)-6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives. Indian J Heterocycl Chem 2021,31(01),57-61","journal-title":"Indian J Heterocycl Chem"},{"key":"ref=130","first-page":"67","volume":"9","author":"Asif M.","year":"2013","unstructured":"Asif M.; Singh A.; Bilkanti L.; In-vivo anticonvulsant and in-vitro antitubercular activity of methyl indole derivative of some 6-aryl-4,5-dihydropyridazin-3(2H)-ones and their expected anticonvulsant mechanisms. Iran J Pharm Sci 2013,9,67-80","journal-title":"Iran J Pharm Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1039\/D0MD00423E","volume":"12","author":"Allart-Simon I.","year":"2021","unstructured":"Allart-Simon I.; Moniot A.; Bisi N.; Ponce-Vargas M.; Audonnet S.; Laronze-Cochard M.; Sapi J.; H\u00e9non E.; Velard F.; G\u00e9rard S.; Pyridazinone derivatives as potential anti-inflammatory agents: Synthesis and biological evaluation as PDE4 inhibitors. RSC Med Chem 2021,12(4),584-592","journal-title":"RSC Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3390\/molecules26082341","volume":"26","author":"Cermola F.","year":"2021","unstructured":"Cermola F.; Vella S.; DellaGreca M.; Tuzi A.; Iesce M.; A one-pot approach to novel pyridazine C-nucleosides. Molecules 2021,26(8),2341","journal-title":"Molecules"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"129435","DOI":"10.1016\/j.molstruc.2020.129435","volume":"1228","author":"Kalai F.E.","year":"2021","unstructured":"Kalai F.E.; \u00c7\u0131nar E.B.; Lai C.H.; Daoui S.; Chelfi T.; Allali M.; Dege N.; Karrouchi K.; Benchat N.; Synthesis, spectroscopy, crystal structure, TGA\/DTA study, DFT and molecular docking investigations of (E)-4-(4-methylbenzyl)-6-styrylpyridazin-3(2H)-one. J Mol Struct 2021,1228,129435","journal-title":"J Mol Struct"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.3390\/molecules27154681","volume":"27","author":"Hoffman G.R.","year":"2022","unstructured":"Hoffman G.R.; Schoffstall A.M.; Syntheses and applications of 1,2,3-triazole-fused pyrazines and pyridazines. Molecules 2022,27(15),4681","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/molecules28031138","volume":"28","author":"Isopi J.","year":"2023","unstructured":"Isopi J.; Quartapelle Procopio E.; Veronese L.; Malferrari M.; Valenti G.; Panigati M.; Paolucci F.; Marcaccio M.; Electrochemical characterization and CO2 reduction reaction of a family of pyridazine-bridged dinuclear Mn(I) Carbonyl complexes. Molecules 2023,28(3),1138","journal-title":"Molecules"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666230913102835","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220995\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666230913102835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T02:16:33Z","timestamp":1730081793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220995\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406419666230913102835","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}